Use of Pneumococcal and influenza vaccine in patients with COPD, asthma bronchiale and interstitial lung diseases in south east Germany
The aim of this study was to analyse use of and adherence to influenza and pneumococcal vaccination in high-risk patients with chronic pulmonary disease. The study was initiated at the Centre of Pneumology in Donaustauf, Germany. All patients with asthma bronchiale (AB), chronic obstructive pulmonar...
Gespeichert in:
| Veröffentlicht in: | Respiratory medicine 2020-11, Vol.174, p.106207-106207, Article 106207 |
|---|---|
| Hauptverfasser: | , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 106207 |
|---|---|
| container_issue | |
| container_start_page | 106207 |
| container_title | Respiratory medicine |
| container_volume | 174 |
| creator | Mohr, Arno Plentz, Annelie Sieroslawski, Anna Pezenburg, Fabian Pfeifer, Michael Salzberger, Bernd Hitzenbichler, Florian |
| description | The aim of this study was to analyse use of and adherence to influenza and pneumococcal vaccination in high-risk patients with chronic pulmonary disease.
The study was initiated at the Centre of Pneumology in Donaustauf, Germany. All patients with asthma bronchiale (AB), chronic obstructive pulmonary disease (COPD) and interstitial lung disease (ILD) that were treated in a pneumological Non-ICU ward, in the sleep laboratory or in the outpatient's clinic between October 1st, 2019 and March 26th, 2020 and provided informed consent were included. Vaccination certificates and a vaccination-centred questionnaire were analysed in relation to vaccination status, risk factors, patient characteristics.
133 patients with COPD, 68 patients with AB and 104 patients with ILD were included. PCV13/PPSV23 vaccination only (no sequential vaccination) was performed in less than 10%/33% of all patients. Sequential vaccination of PCV13 and PPSV23 was performed in 12.8% of COPD, 7.4% of AB patients and 13.5% of ILD patients.
Influenza vaccination was performed in less than 30% of all patients. Vaccinations were mainly performed by general practitioners (GPs) and rarely by specialists of pulmonary care ( |
| doi_str_mv | 10.1016/j.rmed.2020.106207 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_webof</sourceid><recordid>TN_cdi_proquest_miscellaneous_2458034376</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0954611120303474</els_id><sourcerecordid>2461541467</sourcerecordid><originalsourceid>FETCH-LOGICAL-c405t-d096d8afa29db2efd576cf974fa6aa4e07e9e0a5db9157c6934123722550c1ad3</originalsourceid><addsrcrecordid>eNqNkcFu1DAQhiMEokvhBThZ4oIEWWzHdjYSFxRoi1SpPdCzNWtPWK8Se7GdVuUFeG0c7YoDB8TJ9uj7RuP5q-o1o2tGmfqwX8cJ7ZpTvhQUp-2TasVkw-uGKvG0WtFOiloxxs6qFyntKaWdEPR5ddY0THIp-ar6dZeQhIHcepynYIIxMBLwljg_jDP6n0DuwRjnsVTIAbJDnxN5cHlH-pvbz-8JpLybgGxj8GbnYMSTnjGm7HKpkHH234l1CSFhWvqkMBe_PDO5xDiBf3xZPRtgTPjqdJ5XdxdfvvVX9fXN5df-03VtBJW5trRTdgMD8M5uOQ5WtsoMXSsGUAACaYsdUpB22zHZGtU1gvGm5eWz1DCwzXn19tj3EMOPGVPWk0sGxxE8hjlpLuSGNqJpVUHf_IXuwxx9ma5QiknBhGoLxY-UiSGliIM-RDdBfNSM6iUmvddLTHqJSR9jKtLmKD3gNgzJlKUa_COWnGS3DC3Kjcne5bL24Psw-1zUd_-vFvrjkcay03uHUZ8M6yKarG1w_5rzN8XYuyA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2461541467</pqid></control><display><type>article</type><title>Use of Pneumococcal and influenza vaccine in patients with COPD, asthma bronchiale and interstitial lung diseases in south east Germany</title><source>Elsevier ScienceDirect Journals Complete</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Web of Science - Science Citation Index Expanded - 2020<img src="https://exlibris-pub.s3.amazonaws.com/fromwos-v2.jpg" /></source><creator>Mohr, Arno ; Plentz, Annelie ; Sieroslawski, Anna ; Pezenburg, Fabian ; Pfeifer, Michael ; Salzberger, Bernd ; Hitzenbichler, Florian</creator><creatorcontrib>Mohr, Arno ; Plentz, Annelie ; Sieroslawski, Anna ; Pezenburg, Fabian ; Pfeifer, Michael ; Salzberger, Bernd ; Hitzenbichler, Florian</creatorcontrib><description>The aim of this study was to analyse use of and adherence to influenza and pneumococcal vaccination in high-risk patients with chronic pulmonary disease.
The study was initiated at the Centre of Pneumology in Donaustauf, Germany. All patients with asthma bronchiale (AB), chronic obstructive pulmonary disease (COPD) and interstitial lung disease (ILD) that were treated in a pneumological Non-ICU ward, in the sleep laboratory or in the outpatient's clinic between October 1st, 2019 and March 26th, 2020 and provided informed consent were included. Vaccination certificates and a vaccination-centred questionnaire were analysed in relation to vaccination status, risk factors, patient characteristics.
133 patients with COPD, 68 patients with AB and 104 patients with ILD were included. PCV13/PPSV23 vaccination only (no sequential vaccination) was performed in less than 10%/33% of all patients. Sequential vaccination of PCV13 and PPSV23 was performed in 12.8% of COPD, 7.4% of AB patients and 13.5% of ILD patients.
Influenza vaccination was performed in less than 30% of all patients. Vaccinations were mainly performed by general practitioners (GPs) and rarely by specialists of pulmonary care (<6%). 67% of all patients were seen by a specialist in pulmonary care in the last 36 months, but in less than 15% the vaccination status was evaluated.
Use of and adherence for PPSV23 and influenza vaccinations is low in patients with COPD, AB and ILD in south east Germany.
•Adherence to influenza and pneumococcal vaccination is low even in high-risk patients.•Vaccinations are almost exclusively performed by general practitioners.•Side effects are rare in a high-risk population.•Patients are willing to get vaccinated if recommended by the treating physician.</description><identifier>ISSN: 0954-6111</identifier><identifier>EISSN: 1532-3064</identifier><identifier>DOI: 10.1016/j.rmed.2020.106207</identifier><identifier>PMID: 33152552</identifier><language>eng</language><publisher>LONDON: Elsevier Ltd</publisher><subject>Age ; Asthma ; Cardiac & Cardiovascular Systems ; Cardiovascular System & Cardiology ; Chronic obstructive pulmonary disease ; Chronic pulmonary disease ; Disease prevention ; Immunization ; Influenza ; Influenza vaccination ; Informed consent ; Life Sciences & Biomedicine ; Liver diseases ; Lung diseases ; Mortality ; Obstructive lung disease ; Pathogens ; Patients ; Pneumococcal vaccination ; Pneumonia ; Questionnaires ; Respiratory System ; Risk analysis ; Risk factors ; Risk groups ; Science & Technology ; Sleep ; Streptococcus infections ; Vaccination ; Vaccines</subject><ispartof>Respiratory medicine, 2020-11, Vol.174, p.106207-106207, Article 106207</ispartof><rights>2020 Elsevier Ltd</rights><rights>2020. Elsevier Ltd</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>true</woscitedreferencessubscribed><woscitedreferencescount>11</woscitedreferencescount><woscitedreferencesoriginalsourcerecordid>wos000593722400015</woscitedreferencesoriginalsourcerecordid><citedby>FETCH-LOGICAL-c405t-d096d8afa29db2efd576cf974fa6aa4e07e9e0a5db9157c6934123722550c1ad3</citedby><cites>FETCH-LOGICAL-c405t-d096d8afa29db2efd576cf974fa6aa4e07e9e0a5db9157c6934123722550c1ad3</cites><orcidid>0000-0003-4374-2787</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.rmed.2020.106207$$EHTML$$P50$$Gelsevier$$Hfree_for_read</linktohtml><link.rule.ids>315,781,785,3551,27929,27930,28253,46000</link.rule.ids></links><search><creatorcontrib>Mohr, Arno</creatorcontrib><creatorcontrib>Plentz, Annelie</creatorcontrib><creatorcontrib>Sieroslawski, Anna</creatorcontrib><creatorcontrib>Pezenburg, Fabian</creatorcontrib><creatorcontrib>Pfeifer, Michael</creatorcontrib><creatorcontrib>Salzberger, Bernd</creatorcontrib><creatorcontrib>Hitzenbichler, Florian</creatorcontrib><title>Use of Pneumococcal and influenza vaccine in patients with COPD, asthma bronchiale and interstitial lung diseases in south east Germany</title><title>Respiratory medicine</title><addtitle>RESP MED</addtitle><description>The aim of this study was to analyse use of and adherence to influenza and pneumococcal vaccination in high-risk patients with chronic pulmonary disease.
The study was initiated at the Centre of Pneumology in Donaustauf, Germany. All patients with asthma bronchiale (AB), chronic obstructive pulmonary disease (COPD) and interstitial lung disease (ILD) that were treated in a pneumological Non-ICU ward, in the sleep laboratory or in the outpatient's clinic between October 1st, 2019 and March 26th, 2020 and provided informed consent were included. Vaccination certificates and a vaccination-centred questionnaire were analysed in relation to vaccination status, risk factors, patient characteristics.
133 patients with COPD, 68 patients with AB and 104 patients with ILD were included. PCV13/PPSV23 vaccination only (no sequential vaccination) was performed in less than 10%/33% of all patients. Sequential vaccination of PCV13 and PPSV23 was performed in 12.8% of COPD, 7.4% of AB patients and 13.5% of ILD patients.
Influenza vaccination was performed in less than 30% of all patients. Vaccinations were mainly performed by general practitioners (GPs) and rarely by specialists of pulmonary care (<6%). 67% of all patients were seen by a specialist in pulmonary care in the last 36 months, but in less than 15% the vaccination status was evaluated.
Use of and adherence for PPSV23 and influenza vaccinations is low in patients with COPD, AB and ILD in south east Germany.
•Adherence to influenza and pneumococcal vaccination is low even in high-risk patients.•Vaccinations are almost exclusively performed by general practitioners.•Side effects are rare in a high-risk population.•Patients are willing to get vaccinated if recommended by the treating physician.</description><subject>Age</subject><subject>Asthma</subject><subject>Cardiac & Cardiovascular Systems</subject><subject>Cardiovascular System & Cardiology</subject><subject>Chronic obstructive pulmonary disease</subject><subject>Chronic pulmonary disease</subject><subject>Disease prevention</subject><subject>Immunization</subject><subject>Influenza</subject><subject>Influenza vaccination</subject><subject>Informed consent</subject><subject>Life Sciences & Biomedicine</subject><subject>Liver diseases</subject><subject>Lung diseases</subject><subject>Mortality</subject><subject>Obstructive lung disease</subject><subject>Pathogens</subject><subject>Patients</subject><subject>Pneumococcal vaccination</subject><subject>Pneumonia</subject><subject>Questionnaires</subject><subject>Respiratory System</subject><subject>Risk analysis</subject><subject>Risk factors</subject><subject>Risk groups</subject><subject>Science & Technology</subject><subject>Sleep</subject><subject>Streptococcus infections</subject><subject>Vaccination</subject><subject>Vaccines</subject><issn>0954-6111</issn><issn>1532-3064</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><sourceid>AOWDO</sourceid><recordid>eNqNkcFu1DAQhiMEokvhBThZ4oIEWWzHdjYSFxRoi1SpPdCzNWtPWK8Se7GdVuUFeG0c7YoDB8TJ9uj7RuP5q-o1o2tGmfqwX8cJ7ZpTvhQUp-2TasVkw-uGKvG0WtFOiloxxs6qFyntKaWdEPR5ddY0THIp-ar6dZeQhIHcepynYIIxMBLwljg_jDP6n0DuwRjnsVTIAbJDnxN5cHlH-pvbz-8JpLybgGxj8GbnYMSTnjGm7HKpkHH234l1CSFhWvqkMBe_PDO5xDiBf3xZPRtgTPjqdJ5XdxdfvvVX9fXN5df-03VtBJW5trRTdgMD8M5uOQ5WtsoMXSsGUAACaYsdUpB22zHZGtU1gvGm5eWz1DCwzXn19tj3EMOPGVPWk0sGxxE8hjlpLuSGNqJpVUHf_IXuwxx9ma5QiknBhGoLxY-UiSGliIM-RDdBfNSM6iUmvddLTHqJSR9jKtLmKD3gNgzJlKUa_COWnGS3DC3Kjcne5bL24Psw-1zUd_-vFvrjkcay03uHUZ8M6yKarG1w_5rzN8XYuyA</recordid><startdate>202011</startdate><enddate>202011</enddate><creator>Mohr, Arno</creator><creator>Plentz, Annelie</creator><creator>Sieroslawski, Anna</creator><creator>Pezenburg, Fabian</creator><creator>Pfeifer, Michael</creator><creator>Salzberger, Bernd</creator><creator>Hitzenbichler, Florian</creator><general>Elsevier Ltd</general><general>Elsevier</general><general>Elsevier Limited</general><scope>6I.</scope><scope>AAFTH</scope><scope>AOWDO</scope><scope>BLEPL</scope><scope>DTL</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7U9</scope><scope>ASE</scope><scope>FPQ</scope><scope>H94</scope><scope>K6X</scope><scope>K9.</scope><scope>M7N</scope><scope>NAPCQ</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0003-4374-2787</orcidid></search><sort><creationdate>202011</creationdate><title>Use of Pneumococcal and influenza vaccine in patients with COPD, asthma bronchiale and interstitial lung diseases in south east Germany</title><author>Mohr, Arno ; Plentz, Annelie ; Sieroslawski, Anna ; Pezenburg, Fabian ; Pfeifer, Michael ; Salzberger, Bernd ; Hitzenbichler, Florian</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c405t-d096d8afa29db2efd576cf974fa6aa4e07e9e0a5db9157c6934123722550c1ad3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Age</topic><topic>Asthma</topic><topic>Cardiac & Cardiovascular Systems</topic><topic>Cardiovascular System & Cardiology</topic><topic>Chronic obstructive pulmonary disease</topic><topic>Chronic pulmonary disease</topic><topic>Disease prevention</topic><topic>Immunization</topic><topic>Influenza</topic><topic>Influenza vaccination</topic><topic>Informed consent</topic><topic>Life Sciences & Biomedicine</topic><topic>Liver diseases</topic><topic>Lung diseases</topic><topic>Mortality</topic><topic>Obstructive lung disease</topic><topic>Pathogens</topic><topic>Patients</topic><topic>Pneumococcal vaccination</topic><topic>Pneumonia</topic><topic>Questionnaires</topic><topic>Respiratory System</topic><topic>Risk analysis</topic><topic>Risk factors</topic><topic>Risk groups</topic><topic>Science & Technology</topic><topic>Sleep</topic><topic>Streptococcus infections</topic><topic>Vaccination</topic><topic>Vaccines</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Mohr, Arno</creatorcontrib><creatorcontrib>Plentz, Annelie</creatorcontrib><creatorcontrib>Sieroslawski, Anna</creatorcontrib><creatorcontrib>Pezenburg, Fabian</creatorcontrib><creatorcontrib>Pfeifer, Michael</creatorcontrib><creatorcontrib>Salzberger, Bernd</creatorcontrib><creatorcontrib>Hitzenbichler, Florian</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>Web of Science - Science Citation Index Expanded - 2020</collection><collection>Web of Science Core Collection</collection><collection>Science Citation Index Expanded</collection><collection>CrossRef</collection><collection>Virology and AIDS Abstracts</collection><collection>British Nursing Index</collection><collection>British Nursing Index (BNI) (1985 to Present)</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>British Nursing Index</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Nursing & Allied Health Premium</collection><collection>MEDLINE - Academic</collection><jtitle>Respiratory medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Mohr, Arno</au><au>Plentz, Annelie</au><au>Sieroslawski, Anna</au><au>Pezenburg, Fabian</au><au>Pfeifer, Michael</au><au>Salzberger, Bernd</au><au>Hitzenbichler, Florian</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Use of Pneumococcal and influenza vaccine in patients with COPD, asthma bronchiale and interstitial lung diseases in south east Germany</atitle><jtitle>Respiratory medicine</jtitle><stitle>RESP MED</stitle><date>2020-11</date><risdate>2020</risdate><volume>174</volume><spage>106207</spage><epage>106207</epage><pages>106207-106207</pages><artnum>106207</artnum><issn>0954-6111</issn><eissn>1532-3064</eissn><abstract>The aim of this study was to analyse use of and adherence to influenza and pneumococcal vaccination in high-risk patients with chronic pulmonary disease.
The study was initiated at the Centre of Pneumology in Donaustauf, Germany. All patients with asthma bronchiale (AB), chronic obstructive pulmonary disease (COPD) and interstitial lung disease (ILD) that were treated in a pneumological Non-ICU ward, in the sleep laboratory or in the outpatient's clinic between October 1st, 2019 and March 26th, 2020 and provided informed consent were included. Vaccination certificates and a vaccination-centred questionnaire were analysed in relation to vaccination status, risk factors, patient characteristics.
133 patients with COPD, 68 patients with AB and 104 patients with ILD were included. PCV13/PPSV23 vaccination only (no sequential vaccination) was performed in less than 10%/33% of all patients. Sequential vaccination of PCV13 and PPSV23 was performed in 12.8% of COPD, 7.4% of AB patients and 13.5% of ILD patients.
Influenza vaccination was performed in less than 30% of all patients. Vaccinations were mainly performed by general practitioners (GPs) and rarely by specialists of pulmonary care (<6%). 67% of all patients were seen by a specialist in pulmonary care in the last 36 months, but in less than 15% the vaccination status was evaluated.
Use of and adherence for PPSV23 and influenza vaccinations is low in patients with COPD, AB and ILD in south east Germany.
•Adherence to influenza and pneumococcal vaccination is low even in high-risk patients.•Vaccinations are almost exclusively performed by general practitioners.•Side effects are rare in a high-risk population.•Patients are willing to get vaccinated if recommended by the treating physician.</abstract><cop>LONDON</cop><pub>Elsevier Ltd</pub><pmid>33152552</pmid><doi>10.1016/j.rmed.2020.106207</doi><tpages>6</tpages><orcidid>https://orcid.org/0000-0003-4374-2787</orcidid><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0954-6111 |
| ispartof | Respiratory medicine, 2020-11, Vol.174, p.106207-106207, Article 106207 |
| issn | 0954-6111 1532-3064 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_2458034376 |
| source | Elsevier ScienceDirect Journals Complete; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Web of Science - Science Citation Index Expanded - 2020<img src="https://exlibris-pub.s3.amazonaws.com/fromwos-v2.jpg" /> |
| subjects | Age Asthma Cardiac & Cardiovascular Systems Cardiovascular System & Cardiology Chronic obstructive pulmonary disease Chronic pulmonary disease Disease prevention Immunization Influenza Influenza vaccination Informed consent Life Sciences & Biomedicine Liver diseases Lung diseases Mortality Obstructive lung disease Pathogens Patients Pneumococcal vaccination Pneumonia Questionnaires Respiratory System Risk analysis Risk factors Risk groups Science & Technology Sleep Streptococcus infections Vaccination Vaccines |
| title | Use of Pneumococcal and influenza vaccine in patients with COPD, asthma bronchiale and interstitial lung diseases in south east Germany |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-12T00%3A33%3A35IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_webof&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Use%20of%20Pneumococcal%20and%20influenza%20vaccine%20in%20patients%20with%20COPD,%20asthma%20bronchiale%20and%20interstitial%20lung%20diseases%20in%20south%20east%20Germany&rft.jtitle=Respiratory%20medicine&rft.au=Mohr,%20Arno&rft.date=2020-11&rft.volume=174&rft.spage=106207&rft.epage=106207&rft.pages=106207-106207&rft.artnum=106207&rft.issn=0954-6111&rft.eissn=1532-3064&rft_id=info:doi/10.1016/j.rmed.2020.106207&rft_dat=%3Cproquest_webof%3E2461541467%3C/proquest_webof%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2461541467&rft_id=info:pmid/33152552&rft_els_id=S0954611120303474&rfr_iscdi=true |